Aspen Pharmacare Holdings Limited
APNHF
$6.23
-$0.90-12.59%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.39B | 2.44B | 2.48B | 2.43B | 2.39B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.39B | 2.44B | 2.48B | 2.43B | 2.39B |
| Cost of Revenue | 1.34B | 1.35B | 1.36B | 1.36B | 1.35B |
| Gross Profit | 1.05B | 1.09B | 1.12B | 1.08B | 1.04B |
| SG&A Expenses | 602.89M | 587.75M | 571.99M | 555.55M | 540.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 61.97M | 54.30M | 46.77M | 35.34M | 24.10M |
| Total Operating Expenses | 2.00B | 1.99B | 1.98B | 1.95B | 1.92B |
| Operating Income | 385.77M | 445.59M | 503.92M | 488.63M | 474.06M |
| Income Before Tax | -2.22M | 163.77M | 327.50M | 316.24M | 305.59M |
| Income Tax Expenses | 53.32M | 68.14M | 82.69M | 76.30M | 70.05M |
| Earnings from Continuing Operations | -55.54 | 95.63 | 244.81 | 239.94 | 235.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.54M | 95.63M | 244.81M | 239.94M | 235.54M |
| EBIT | 385.77M | 445.59M | 503.92M | 488.63M | 474.06M |
| EBITDA | 469.82M | 529.04M | 586.71M | 567.62M | 549.45M |
| EPS Basic | -0.13 | 0.22 | 0.55 | 0.54 | 0.53 |
| Normalized Basic EPS | 0.42 | 0.51 | 0.60 | 0.59 | 0.57 |
| EPS Diluted | -0.13 | 0.22 | 0.55 | 0.54 | 0.53 |
| Normalized Diluted EPS | 0.42 | 0.51 | 0.60 | 0.59 | 0.57 |
| Average Basic Shares Outstanding | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B |
| Average Diluted Shares Outstanding | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -160.78% | 93.38% | 36.48% | 35.56% | 34.67% |